APO Research
Talk to an analyst

APO RESEARCH · REPORT

Humira

Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation.

Humira is used to treat many inflammatory conditions in adults, such as ulcerative colitis, Rheumatoid Arthritis, psoriatic arthritis, Ankylosing Spondylitis, plaque psoriasis, and a skin condition called hidradenitis suppurativa.

Humira is also used in adults and children to treat Crohn's disease or juvenile idiopathic arthritis.

In 2014, in India, the first adalimumab biosimilar came to market at a price of $200. Two years later, another Indian drugmaker, Torrent Pharmaceuticals, launched a second biosimilar. Humira's U.S. patent expired in 2016.

Selected research

Market Analysis & Forecast

Global Humira Market Analysis and Forecast 2026-2032

23 December 2025194 pages

Choose your research edition.

Industry ResearchHumira Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Humira Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Humira Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Humira Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Humira Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation.

Humira is used to treat many inflammatory conditions in adults, such as ulcerative colitis, Rheumatoid Arthritis, psoriatic arthritis, Ankylosing Spondylitis, plaque psoriasis, and a skin condition called hidradenitis suppurativa.

Humira is also used in adults and children to treat Crohn's disease or juvenile idiopathic arthritis.

Read the full market overview

In 2014, in India, the first adalimumab biosimilar came to market at a price of $200. Two years later, another Indian drugmaker, Torrent Pharmaceuticals, launched a second biosimilar. Humira's U.S. patent expired in 2016.

The classification of Humira includes Humira Syringe and Humira Pen. The proportion of Humira Syringe is about 78%.

Humira is widely used for Ankylosing Spondylitis, Rheumatoid Arthritis, Crohn’s disease and other disease. The most proportion of Humira is for Ankylosing Spondylitis, and the proportion is about 43%.

USA is the largest market, with a sales market share nearly 65%. Following USA, Europe is the second largest market with the sales market share of 30%.

Market competition will intense. AbbVie, Eisai, Cadila Healthcare, Torrent Pharmaceuticals, Amgen and Boehringer Ingelheim are the key manufacturters of Humira. AbbVie is the leader of this industry by 97% market shares.

This report presents an overview of global market for Humira, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Humira, also provides the sales of main regions and countries. Of the upcoming market potential for Humira, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Humira sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Humira market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Humira sales, projected growth trends, production technology, application and end-user industry.

Humira Segment by Company

AbbVie

Eisai

Cadila Healthcare

Torrent Pharmaceuticals

Amgen

Boehringer Ingelheim

Humira Segment by Type

Humira Syringe

Humira Pen

Humira Segment by Application

Ankylosing Spondylitis

Rheumatoid Arthritis

Crohn’s Disease

Others

Humira Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Humira market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Humira and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Humira.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Humira in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Humira manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Humira sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Humira Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Humira Syringe Major Manufacturers Table 3. Humira Pen Major Manufacturers Table 4. Global Humira Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Ankylosing Spondylitis Major Manufacturers Table 6. Rheumatoid Arthritis Major Manufacturers Table 7. Crohn’s Disease Major Manufacturers Table 8. Others Major Manufacturers Table 9. Humira Industry Trends Table 10. Humira Industry Drivers Table 11. Humira Industry Opportunities and Challenges Table 12. Humira Industry Restraints Table 13. Global Humira Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Humira Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Humira Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Humira Revenue Market Share by Region (2021-2026) Table 17. Global Humira Revenue Market Share by Region (2027-2032) Table 18. Global Humira Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Humira Sales by Region (2021-2026) & (K Units) Table 20. Global Humira Sales by Region (2027-2032) & (K Units) Table 21. Global Humira Sales Market Share by Region (2021-2026) Table 22. Global Humira Sales Market Share by Region (2027-2032) Table 23. Global Humira Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Humira Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Humira Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Humira Sales Market Share by Manufacturers (2021-2026) Table 27. Global Humira Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 28. Global Humira Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Humira Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Humira Manufacturers, Product Type & Application Table 31. Global Humira Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Humira by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Humira Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Humira Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Humira Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Humira Revenue Market Share by Type (2021-2026) Table 38. Global Humira Revenue Market Share by Type (2027-2032) Table 39. Global Humira Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Humira Sales by Type (2021-2026) & (K Units) Table 41. Global Humira Sales by Type (2027-2032) & (K Units) Table 42. Global Humira Sales Market Share by Type (2021-2026) Table 43. Global Humira Sales Market Share by Type (2027-2032) Table 44. Global Humira Price by Type (2021-2026) & (USD/Unit) Table 45. Global Humira Price by Type (2027-2032) & (USD/Unit) Table 46. Global Humira Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Humira Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Humira Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Humira Revenue Market Share by Application (2021-2026) Table 50. Global Humira Revenue Market Share by Application (2027-2032) Table 51. Global Humira Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Humira Sales by Application (2021-2026) & (K Units) Table 53. Global Humira Sales by Application (2027-2032) & (K Units) Table 54. Global Humira Sales Market Share by Application (2021-2026) Table 55. Global Humira Sales Market Share by Application (2027-2032) Table 56. Global Humira Price by Application (2021-2026) & (USD/Unit) Table 57. Global Humira Price by Application (2027-2032) & (USD/Unit) Table 58. AbbVie Company Information Table 59. AbbVie Business Overview Table 60. AbbVie Humira Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 61. AbbVie Humira Product Portfolio Table 62. AbbVie Recent Development Table 63. Eisai Company Information Table 64. Eisai Business Overview Table 65. Eisai Humira Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 66. Eisai Humira Product Portfolio Table 67. Eisai Recent Development Table 68. Cadila Healthcare Company Information Table 69. Cadila Healthcare Business Overview Table 70. Cadila Healthcare Humira Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 71. Cadila Healthcare Humira Product Portfolio Table 72. Cadila Healthcare Recent Development Table 73. Torrent Pharmaceuticals Company Information Table 74. Torrent Pharmaceuticals Business Overview Table 75. Torrent Pharmaceuticals Humira Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 76. Torrent Pharmaceuticals Humira Product Portfolio Table 77. Torrent Pharmaceuticals Recent Development Table 78. Amgen Company Information Table 79. Amgen Business Overview Table 80. Amgen Humira Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 81. Amgen Humira Product Portfolio Table 82. Amgen Recent Development Table 83. Boehringer Ingelheim Company Information Table 84. Boehringer Ingelheim Business Overview Table 85. Boehringer Ingelheim Humira Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 86. Boehringer Ingelheim Humira Product Portfolio Table 87. Boehringer Ingelheim Recent Development Table 88. North America Humira Revenue by Type (2021-2026) & (US$ Million) Table 89. North America Humira Revenue by Type (2027-2032) & (US$ Million) Table 90. North America Humira Sales by Type (2021-2026) & (K Units) Table 91. North America Humira Sales by Type (2027-2032) & (K Units) Table 92. North America Humira Sales Price by Type (2021-2026) & (USD/Unit) Table 93. North America Humira Sales Price by Type (2027-2032) & (USD/Unit) Table 94. North America Humira Revenue by Application (2021-2026) & (US$ Million) Table 95. North America Humira Revenue by Application (2027-2032) & (US$ Million) Table 96. North America Humira Sales by Application (2021-2026) & (K Units) Table 97. North America Humira Sales by Application (2027-2032) & (K Units) Table 98. North America Humira Sales Price by Application (2021-2026) & (USD/Unit) Table 99. North America Humira Sales Price by Application (2027-2032) & (USD/Unit) Table 100. North America Humira Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. North America Humira Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 102. North America Humira Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 103. North America Humira Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 104. North America Humira Sales by Country (2021-2026) & (K Units) Table 105. North America Humira Sales by Country (2027-2032) & (K Units) Table 106. North America Humira Sales Price by Country (2021-2026) & (USD/Unit) Table 107. North America Humira Sales Price by Country (2027-2032) & (USD/Unit) Table 108. United States Humira Revenue (2021-2032) & (US$ Million) Table 109. Canada Humira Revenue (2021-2032) & (US$ Million) Table 110. Mexico Humira Revenue (2021-2032) & (US$ Million) Table 111. Europe Humira Revenue by Type (2021-2026) & (US$ Million) Table 112. Europe Humira Revenue by Type (2027-2032) & (US$ Million) Table 113. Europe Humira Sales by Type (2021-2026) & (K Units) Table 114. Europe Humira Sales by Type (2027-2032) & (K Units) Table 115. Europe Humira Sales Price by Type (2021-2026) & (USD/Unit) Table 116. Europe Humira Sales Price by Type (2027-2032) & (USD/Unit) Table 117. Europe Humira Revenue by Application (2021-2026) & (US$ Million) Table 118. Europe Humira Revenue by Application (2027-2032) & (US$ Million) Table 119. Europe Humira Sales by Application (2021-2026) & (K Units) Table 120. Europe Humira Sales by Application (2027-2032) & (K Units) Table 121. Europe Humira Sales Price by Application (2021-2026) & (USD/Unit) Table 122. Europe Humira Sales Price by Application (2027-2032) & (USD/Unit) Table 123. Europe Humira Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 124. Europe Humira Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 125. Europe Humira Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 126. Europe Humira Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 127. Europe Humira Sales by Country (2021-2026) & (K Units) Table 128. Europe Humira Sales by Country (2027-2032) & (K Units) Table 129. Europe Humira Sales Price by Country (2021-2026) & (USD/Unit) Table 130. Europe Humira Sales Price by Country (2027-2032) & (USD/Unit) Table 131. Germany Humira Revenue (2021-2032) & (US$ Million) Table 132. France Humira Revenue (2021-2032) & (US$ Million) Table 133. U.K. Humira Revenue (2021-2032) & (US$ Million) Table 134. Italy Humira Revenue (2021-2032) & (US$ Million) Table 135. Russia Humira Revenue (2021-2032) & (US$ Million) Table 136. Spain Humira Revenue (2021-2032) & (US$ Million) Table 137. Netherlands Humira Revenue (2021-2032) & (US$ Million) Table 138. Switzerland Humira Revenue (2021-2032) & (US$ Million) Table 139. Sweden Humira Revenue (2021-2032) & (US$ Million) Table 140. Poland Humira Revenue (2021-2032) & (US$ Million) Table 141. China Humira Revenue by Type (2021-2026) & (US$ Million) Table 142. China Humira Revenue by Type (2027-2032) & (US$ Million) Table 143. China Humira Sales by Type (2021-2026) & (K Units) Table 144. China Humira Sales by Type (2027-2032) & (K Units) Table 145. China Humira Sales Price by Type (2021-2026) & (USD/Unit) Table 146. China Humira Sales Price by Type (2027-2032) & (USD/Unit) Table 147. China Humira Revenue by Application (2021-2026) & (US$ Million) Table 148. China Humira Revenue by Application (2027-2032) & (US$ Million) Table 149. China Humira Sales by Application (2021-2026) & (K Units) Table 150. China Humira Sales by Application (2027-2032) & (K Units) Table 151. China Humira Sales Price by Application (2021-2026) & (USD/Unit) Table 152. China Humira Sales Price by Application (2027-2032) & (USD/Unit) Table 153. Asia Humira Revenue by Type (2021-2026) & (US$ Million) Table 154. Asia Humira Revenue by Type (2027-2032) & (US$ Million) Table 155. Asia Humira Sales by Type (2021-2026) & (K Units) Table 156. Asia Humira Sales by Type (2027-2032) & (K Units) Table 157. Asia Humira Sales Price by Type (2021-2026) & (USD/Unit) Table 158. Asia Humira Sales Price by Type (2027-2032) & (USD/Unit) Table 159. Asia Humira Revenue by Application (2021-2026) & (US$ Million) Table 160. Asia Humira Revenue by Application (2027-2032) & (US$ Million) Table 161. Asia Humira Sales by Application (2021-2026) & (K Units) Table 162. Asia Humira Sales by Application (2027-2032) & (K Units) Table 163. Asia Humira Sales Price by Application (2021-2026) & (USD/Unit) Table 164. Asia Humira Sales Price by Application (2027-2032) & (USD/Unit) Table 165. Asia Humira Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 166. Asia Humira Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 167. Asia Humira Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 168. Asia Humira Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 169. Asia Humira Sales by Country (2021-2026) & (K Units) Table 170. Asia Humira Sales by Country (2027-2032) & (K Units) Table 171. Asia Humira Sales Price by Country (2021-2026) & (USD/Unit) Table 172. Asia Humira Sales Price by Country (2027-2032) & (USD/Unit) Table 173. Japan Humira Revenue (2021-2032) & (US$ Million) Table 174. South Korea Humira Revenue (2021-2032) & (US$ Million) Table 175. India Humira Revenue (2021-2032) & (US$ Million) Table 176. Australia Humira Revenue (2021-2032) & (US$ Million) Table 177. Taiwan Humira Revenue (2021-2032) & (US$ Million) Table 178. Southeast Asia Humira Revenue (2021-2032) & (US$ Million) Table 179. SAMEA Humira Revenue by Type (2021-2026) & (US$ Million) Table 180. SAMEA Humira Revenue by Type (2027-2032) & (US$ Million) Table 181. SAMEA Humira Sales by Type (2021-2026) & (K Units) Table 182. SAMEA Humira Sales by Type (2027-2032) & (K Units) Table 183. SAMEA Humira Sales Price by Type (2021-2026) & (USD/Unit) Table 184. SAMEA Humira Sales Price by Type (2027-2032) & (USD/Unit) Table 185. SAMEA Humira Revenue by Application (2021-2026) & (US$ Million) Table 186. SAMEA Humira Revenue by Application (2027-2032) & (US$ Million) Table 187. SAMEA Humira Sales by Application (2021-2026) & (K Units) Table 188. SAMEA Humira Sales by Application (2027-2032) & (K Units) Table 189. SAMEA Humira Sales Price by Application (2021-2026) & (USD/Unit) Table 190. SAMEA Humira Sales Price by Application (2027-2032) & (USD/Unit) Table 191. SAMEA Humira Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 192. SAMEA Humira Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 193. SAMEA Humira Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 194. SAMEA Humira Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 195. SAMEA Humira Sales by Country (2021-2026) & (K Units) Table 196. SAMEA Humira Sales by Country (2027-2032) & (K Units) Table 197. SAMEA Humira Sales Price by Country (2021-2026) & (USD/Unit) Table 198. SAMEA Humira Sales Price by Country (2027-2032) & (USD/Unit) Table 199. Brazil Humira Revenue (2021-2032) & (US$ Million) Table 200. Argentina Humira Revenue (2021-2032) & (US$ Million) Table 201. Chile Humira Revenue (2021-2032) & (US$ Million) Table 202. Colombia Humira Revenue (2021-2032) & (US$ Million) Table 203. Peru Humira Revenue (2021-2032) & (US$ Million) Table 204. Saudi Arabia Humira Revenue (2021-2032) & (US$ Million) Table 205. Israel Humira Revenue (2021-2032) & (US$ Million) Table 206. UAE Humira Revenue (2021-2032) & (US$ Million) Table 207. Turkey Humira Revenue (2021-2032) & (US$ Million) Table 208. Iran Humira Revenue (2021-2032) & (US$ Million) Table 209. Egypt Humira Revenue (2021-2032) & (US$ Million) Table 210. Key Raw Materials Table 211. Raw Materials Key Suppliers Table 212. Humira Distributors List Table 213. Humira Customers List Table 214. Research Programs/Design for This Report Table 215. Authors List of This Report Table 216. Secondary Sources Table 217. Primary Sources List of Figures Figure 1. Humira Image Figure 2. Global Humira Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Humira Market Size Share 2021 VS 2025 VS 2032 Figure 4. Humira Syringe Image Figure 5. Humira Pen Image Figure 6. Global Humira Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Humira Market Size Share 2021 VS 2025 VS 2032 Figure 8. Ankylosing Spondylitis Image Figure 9. Rheumatoid Arthritis Image Figure 10. Crohn’s Disease Image Figure 11. Others Image Figure 12. Global Humira Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Humira Revenue (2021-2032) & (US$ Million) Figure 14. Global Humira Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Humira Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Humira Revenue Market Share by Region (2021-2032) Figure 17. Global Humira Sales (2021-2032) & (K Units) Figure 18. Global Humira Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Humira Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Humira Sales YoY (2021-2032) & (K Units) Figure 21. Europe Humira Sales YoY (2021-2032) & (K Units) Figure 22. China Humira Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Humira Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Humira Sales YoY (2021-2032) & (K Units) Figure 25. Global Humira Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Humira Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Humira Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Humira Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Humira Revenue Market Share by Type (2021-2032) Figure 31. Global Humira Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Humira Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Humira Sales Market Share by Type (2021-2032) Figure 34. Global Humira Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Humira Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Humira Revenue Market Share by Application (2021-2032) Figure 37. Global Humira Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Humira Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Humira Sales Market Share by Application (2021-2032) Figure 40. North America Humira Revenue Share by Type (2021-2032) Figure 41. North America Humira Sales Share by Type (2021-2032) Figure 42. North America Humira Revenue Share by Application (2021-2032) Figure 43. North America Humira Sales Share by Application (2021-2032) Figure 44. North America Humira Revenue Share by Country (2021-2032) Figure 45. North America Humira Sales Share by Country (2021-2032) Figure 46. Europe Humira Revenue Share by Type (2021-2032) Figure 47. Europe Humira Sales Share by Type (2021-2032) Figure 48. Europe Humira Revenue Share by Application (2021-2032) Figure 49. Europe Humira Sales Share by Application (2021-2032) Figure 50. Europe Humira Revenue Share by Country (2021-2032) Figure 51. Europe Humira Sales Share by Country (2021-2032) Figure 52. China Humira Revenue Share by Type (2021-2032) Figure 53. China Humira Sales Share by Type (2021-2032) Figure 54. China Humira Revenue Share by Application (2021-2032) Figure 55. China Humira Sales Share by Application (2021-2032) Figure 56. Asia Humira Revenue Share by Type (2021-2032) Figure 57. Asia Humira Sales Share by Type (2021-2032) Figure 58. Asia Humira Revenue Share by Application (2021-2032) Figure 59. Asia Humira Sales Share by Application (2021-2032) Figure 60. Asia Humira Revenue Share by Country (2021-2032) Figure 61. Asia Humira Sales Share by Country (2021-2032) Figure 62. SAMEA Humira Revenue Share by Type (2021-2032) Figure 63. SAMEA Humira Sales Share by Type (2021-2032) Figure 64. SAMEA Humira Revenue Share by Application (2021-2032) Figure 65. SAMEA Humira Sales Share by Application (2021-2032) Figure 66. SAMEA Humira Revenue Share by Country (2021-2032) Figure 67. SAMEA Humira Sales Share by Country (2021-2032) Figure 68. Humira Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Humira Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Humira Syringe
  • Humira Pen
Applications
  • Ankylosing Spondylitis
  • Rheumatoid Arthritis
  • Crohn’s Disease
  • Others
Companies covered
  • AbbVie
  • Eisai
  • Cadila Healthcare
  • Torrent Pharmaceuticals
  • Amgen
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Humira Market by Type
  3. 1.2.1 Global Humira Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Humira Syringe
  5. 1.2.3 Humira Pen
  6. 1.3 Humira Market by Application
  7. 1.3.1 Global Humira Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Ankylosing Spondylitis
  9. 1.3.3 Rheumatoid Arthritis
  10. 1.3.4 Crohn’s Disease
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Humira Market Dynamics
  1. 2.1 Humira Industry Trends
  2. 2.2 Humira Industry Drivers
  3. 2.3 Humira Industry Opportunities and Challenges
  4. 2.4 Humira Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Humira Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Humira Revenue by Region
  3. 3.2.1 Global Humira Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Humira Revenue by Region (2021-2026)
  5. 3.2.3 Global Humira Revenue by Region (2027-2032)
  6. 3.2.4 Global Humira Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Humira Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Humira Sales by Region
  9. 3.4.1 Global Humira Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Humira Sales by Region (2021-2026)
  11. 3.4.3 Global Humira Sales by Region (2027-2032)
  12. 3.4.4 Global Humira Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Humira Revenue by Manufacturers
  2. 4.1.1 Global Humira Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Humira Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Humira Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Humira Sales by Manufacturers
  6. 4.2.1 Global Humira Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Humira Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Humira Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Humira Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Humira Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Humira Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Humira Manufacturers, Product Type & Application
  13. 4.7 Global Humira Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Humira Market CR5 and HHI
  16. 4.8.2 2025 Humira Tier 1, Tier 2, and Tier 3
5 Humira Market by Type
  1. 5.1 Global Humira Revenue by Type
  2. 5.1.1 Global Humira Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Humira Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Humira Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Humira Sales by Type
  6. 5.2.1 Global Humira Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Humira Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Humira Sales Market Share by Type (2021-2032)
  9. 5.3 Global Humira Price by Type
6 Humira Market by Application
  1. 6.1 Global Humira Revenue by Application
  2. 6.1.1 Global Humira Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Humira Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Humira Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Humira Sales by Application
  6. 6.2.1 Global Humira Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Humira Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Humira Sales Market Share by Application (2021-2032)
  9. 6.3 Global Humira Price by Application
7 Company Profiles
  1. 7.1 AbbVie
  2. 7.1.1 AbbVie Company Information
  3. 7.1.2 AbbVie Business Overview
  4. 7.1.3 AbbVie Humira Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 AbbVie Humira Product Portfolio
  6. 7.1.5 AbbVie Recent Developments
  7. 7.2 Eisai
  8. 7.2.1 Eisai Company Information
  9. 7.2.2 Eisai Business Overview
  10. 7.2.3 Eisai Humira Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Eisai Humira Product Portfolio
  12. 7.2.5 Eisai Recent Developments
  13. 7.3 Cadila Healthcare
  14. 7.3.1 Cadila Healthcare Company Information
  15. 7.3.2 Cadila Healthcare Business Overview
  16. 7.3.3 Cadila Healthcare Humira Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Cadila Healthcare Humira Product Portfolio
  18. 7.3.5 Cadila Healthcare Recent Developments
  19. 7.4 Torrent Pharmaceuticals
  20. 7.4.1 Torrent Pharmaceuticals Company Information
  21. 7.4.2 Torrent Pharmaceuticals Business Overview
  22. 7.4.3 Torrent Pharmaceuticals Humira Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Torrent Pharmaceuticals Humira Product Portfolio
  24. 7.4.5 Torrent Pharmaceuticals Recent Developments
  25. 7.5 Amgen
  26. 7.5.1 Amgen Company Information
  27. 7.5.2 Amgen Business Overview
  28. 7.5.3 Amgen Humira Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Amgen Humira Product Portfolio
  30. 7.5.5 Amgen Recent Developments
  31. 7.6 Boehringer Ingelheim
  32. 7.6.1 Boehringer Ingelheim Company Information
  33. 7.6.2 Boehringer Ingelheim Business Overview
  34. 7.6.3 Boehringer Ingelheim Humira Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Boehringer Ingelheim Humira Product Portfolio
  36. 7.6.5 Boehringer Ingelheim Recent Developments
8 North America
  1. 8.1 North America Humira Market Size by Type
  2. 8.1.1 North America Humira Revenue by Type (2021-2032)
  3. 8.1.2 North America Humira Sales by Type (2021-2032)
  4. 8.1.3 North America Humira Price by Type (2021-2032)
  5. 8.2 North America Humira Market Size by Application
  6. 8.2.1 North America Humira Revenue by Application (2021-2032)
  7. 8.2.2 North America Humira Sales by Application (2021-2032)
  8. 8.2.3 North America Humira Price by Application (2021-2032)
  9. 8.3 North America Humira Market Size by Country
  10. 8.3.1 North America Humira Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Humira Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Humira Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Humira Market Size by Type
  2. 9.1.1 Europe Humira Revenue by Type (2021-2032)
  3. 9.1.2 Europe Humira Sales by Type (2021-2032)
  4. 9.1.3 Europe Humira Price by Type (2021-2032)
  5. 9.2 Europe Humira Market Size by Application
  6. 9.2.1 Europe Humira Revenue by Application (2021-2032)
  7. 9.2.2 Europe Humira Sales by Application (2021-2032)
  8. 9.2.3 Europe Humira Price by Application (2021-2032)
  9. 9.3 Europe Humira Market Size by Country
  10. 9.3.1 Europe Humira Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Humira Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Humira Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Humira Market Size by Type
  2. 10.1.1 China Humira Revenue by Type (2021-2032)
  3. 10.1.2 China Humira Sales by Type (2021-2032)
  4. 10.1.3 China Humira Price by Type (2021-2032)
  5. 10.2 China Humira Market Size by Application
  6. 10.2.1 China Humira Revenue by Application (2021-2032)
  7. 10.2.2 China Humira Sales by Application (2021-2032)
  8. 10.2.3 China Humira Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Humira Market Size by Type
  2. 11.1.1 Asia Humira Revenue by Type (2021-2032)
  3. 11.1.2 Asia Humira Sales by Type (2021-2032)
  4. 11.1.3 Asia Humira Price by Type (2021-2032)
  5. 11.2 Asia Humira Market Size by Application
  6. 11.2.1 Asia Humira Revenue by Application (2021-2032)
  7. 11.2.2 Asia Humira Sales by Application (2021-2032)
  8. 11.2.3 Asia Humira Price by Application (2021-2032)
  9. 11.3 Asia Humira Market Size by Country
  10. 11.3.1 Asia Humira Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Humira Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Humira Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Humira Market Size by Type
  2. 12.1.1 SAMEA Humira Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Humira Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Humira Price by Type (2021-2032)
  5. 12.2 SAMEA Humira Market Size by Application
  6. 12.2.1 SAMEA Humira Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Humira Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Humira Price by Application (2021-2032)
  9. 12.3 SAMEA Humira Market Size by Country
  10. 12.3.1 SAMEA Humira Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Humira Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Humira Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Humira Value Chain Analysis
  2. 13.1.1 Humira Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Humira Production Mode & Process
  6. 13.2 Humira Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Humira Distributors
  9. 13.2.3 Humira Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst